Libramed Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.61 M
- Revenue Growth 35.83%
- Profit Growth 35.12%
- Ebitda 47.65%
- Net Worth 58.00%
- Total Assets 132.69%
About Libramed Pharmaceuticals
Libramed Pharmaceuticals Private Limited (LPPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 May 2019 (Five years and nine months 23 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹7.61 M.
Balakrishna Dyavanapelly, Mahendhar Punnam, Pannala Reddy, and Four other members serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U52599TG2019PTC132443
- Company No.
132443
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 May 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Libramed Pharmaceuticals?
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Balakrishna Dyavanapelly  | Director | 01-May-2019 | Current |
| Mahendhar Punnam | Director | 01-May-2019 | Current |
| Pannala Reddy | Director | 26-Jul-2019 | Current |
| Vijayalakshmi | Director | 21-Oct-2022 | Current |
| Naresh Gundluru | Additional Director | 20-Jul-2022 | Current |
| Bharath Gajula | Director | 21-Oct-2022 | Current |
Financial Performance of Libramed Pharmaceuticals.
Libramed Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 35.83% increase. The company also saw a substantial improvement in profitability, with a 35.12% increase in profit. The company's net worth Soared by an impressive increase of 58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Libramed Pharmaceuticals?
Unlock access to Libramed Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Ojasinfinity Pharma Private LimitedVijayalakshmi is a mutual person
- Jaya Vaaraahi Hospitals Private Limited
Vijayalakshmi and Naresh Gundluru are mutual person
Charges (Loans)
₹7.61 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.76 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Dec 2023 | Others | ₹7.61 M | Open |
How Many Employees Work at Libramed Pharmaceuticals?
Libramed Pharmaceuticals has a workforce of 27 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Libramed Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Libramed Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
